Treatment of purely cutaneous ​Rosai-Dorfman disease with topical rapamycin

Clin Exp Dermatol. 2023 Apr 27;48(5):545-547. doi: 10.1093/ced/llad018.
No abstract available

Publication types

  • Letter

MeSH terms

  • Histiocytosis, Sinus* / drug therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Sirolimus / therapeutic use
  • Skin Diseases*

Substances

  • Immunosuppressive Agents
  • Sirolimus